Tuberculosis and HIV: latest news

Tuberculosis and HIV resources

Tuberculosis and HIV features

Tuberculosis and HIV in your own words

Tuberculosis and HIV news from aidsmap

More news

Tuberculosis and HIV news selected from other sources

  • TB to cost world economy $1 trillion by 2030, warns report

    Tuberculosis will cost the world economy close to $1 trillion in lost economic output by 2030, unless countries step up efforts to fight the disease, according to a report launched today by the Global TB Caucus, a group of over 2,300 parliamentarians from 130 countries. The disease cost the world more than $600 billion from 2000 to 2015.

    15 November 2017 | Devex
  • WHO report signals urgent need for greater political commitment to end tuberculosis

    Global efforts to combat tuberculosis (TB) have saved an estimated 53 million lives since 2000 and reduced the TB mortality rate by 37%, according to the Global TB Report 2017, released by WHO today. Despite these achievements, the latest picture is grim. TB remains the top infectious killer in 2016. TB is also the main cause of deaths related to antimicrobial resistance and the leading killer of people with HIV. Progress in most countries is stalling and is not fast enough to reach global targets or close persistent gaps in TB care and prevention.

    30 October 2017 | World Health Organization
  • Personal Stories from TB Survivors

    These are the stories of TB survivors from around the world on their journey fighting and beating TB. These survivors have experienced the side effects of TB medication, the difficulties of undergoing treatment, the mental and psychological impact, and want to raise awareness about this disease, including the importance of getting tested and adhering to treatment. Their voices provide important perspectives and are a powerful tool for advocacy to accelerate the TB response and reach all affected people with prevention and care.

    30 October 2017 | World Health Organization
  • Advocates to seek TB funding targets at 2018 high-level meeting

    Global tuberculosis experts want to see numerical funding targets for combating the epidemic set at the first United Nations high-level meeting on the disease next year. Experts want to set additional targets for 2020 and 2025.

    20 October 2017 | Devex
  • TB Alliance Moves Two Novel Tuberculosis Drugs into Human Trials

    TBA-7371 and Sutezolid Help Fill Sparse Pipeline of New Antibiotics Against a Disease That Grows Increasingly Resistant to Older Drugs.

    11 October 2017 | TB Alliance
  • Ukraine’s TB problem is ticking time bomb for Europe

    Controlling the airborne disease takes on additional urgency this year as the country seeks to integrate into EU with a new visa-free regime.

    29 August 2017 | Politico
  • South Africa death rates declined due to HIV success – report

    Death rates have declined, largely due to successes in HIV, but a lot more needs to be done to defeat its “terrible twin”, tuberculosis (TB).

    23 August 2017 | Health-e
  • X-DR TB emerged in 1990s in South Africa fueled by HIV

    Extensively drug resistant tuberculosis emerged and was widely transmitted in South Africa long before it was spotted by public health surveillance efforts, and at least a decade earlier than the first reported outbreak in 2005, a  presentation Monday showed.

    26 July 2017 | Science Speaks
  • We had to run our own trial for TB drugs – nobody else was doing it

    Four years ago, Médecins Sans Frontières (MSF) made the decision to sponsor and run its own tuberculosis clinical trial. The aim was to find a new treatment regimen for drug-resistant tuberculosis (TB) that was radically better than what was currently available. As an organisation that specialises in delivering short-term emergency healthcare, this was a bold and new direction to take. But it was a decision that came from our frustration, anger and impatience on behalf of the more than 20,000 people with TB that we treat every year. We felt compelled to search for improved treatments ourselves because too few pharmaceutical companies, organisations or universities were doing enough about it.

    02 June 2017 | The Guardian
  • South Africa: 'We Can't Accept the New HIV, TB Plan' - Treatment Action Campaign

    The new national strategic plan for HIV and TB is a plan that seems reasonable when considered in the abstract, but that risks falling apart when confronted by the realities of the public healthcare system and political context.

    04 April 2017 | AllAfrica
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.